Axe Compute Net Acquisitions/Divestitures 2012-2026 | AGPU
Axe Compute net acquisitions/divestitures from 2012 to 2026. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
|
Axe Compute Annual Net Acquisitions/Divestitures (Millions of US $) |
|
|---|---|
| 2025 | N/A |
| 2024 | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | $-10 |
| 2020 | N/A |
| 2019 | $0 |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
| 2015 | N/A |
| 2014 | N/A |
| 2013 | N/A |
| 2012 | N/A |
| 2011 | N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.022B | $0.000B |
| Axe Compute Inc. is engaged in using artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients. Axe Compute Inc., formerly known as Predictive Oncology Inc., is based in PITTSBURGH, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |